We are live on
!
Find out more
AstraZeneca
AZN
AZN
785 hedge funds and large institutions have $19.7B invested in AstraZeneca in 2020 Q4 according to their latest regulatory filings, with 150 funds opening new positions, 271 increasing their positions, 226 reducing their positions, and 76 closing their positions.
New
Increased
Maintained
Reduced
Closed
200% more funds holding in top 10
Funds holding in top 10: 6 → 18 (+12)
97% more first-time investments, than exits
New positions opened: 150 | Existing positions closed: 76
20% more repeat investments, than reductions
Existing positions increased: 271 | Existing positions reduced: 226
9% more funds holding
Funds holding: 722 → 785 (+63)
7% more call options, than puts
Call options by funds: $451M | Put options by funds: $420M
0.52% less ownership
Funds ownership: 15.52% → 15% (-0.52%)
12% less capital invested
Capital invested by funds: $22.3B → $19.7B (-$2.63B)
Holders
785
Holders Change
+63
Holders Change %
+8.73%
% of All Funds
13.89%
Holding in Top 10
18
Holding in Top 10 Change
+12
Holding in Top 10 Change %
+200%
% of All Funds
0.32%
New
150
Increased
271
Reduced
226
Closed
76
Calls
$451M
Puts
$420M
Net Calls
+$31.1M
Net Calls Change
+$28.7M
Top Buyers
| 1 |
BlackRock
New York
|
+$271M |
| 2 |
GQG Partners
Ft. Lauderdale,
Florida
|
+$244M |
| 3 |
D.E. Shaw & Co
New York
|
+$224M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$199M |
| 5 |
Voloridge Investment Management
Jupiter,
Florida
|
+$163M |
